These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15692268)

  • 41. Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma.
    Sabbaghian MS; Rothberger G; Alongi AP; Gagner JP; Goldberg JD; Rolnitzky L; Chiriboga L; Hajdu CH; Zagzag D; Basch R; Shamamian P
    Anticancer Res; 2010 Jul; 30(7):2911-7. PubMed ID: 20683032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.
    Monestiroli S; Mancuso P; Burlini A; Pruneri G; Dell'Agnola C; Gobbi A; Martinelli G; Bertolini F
    Cancer Res; 2001 Jun; 61(11):4341-4. PubMed ID: 11389057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of YangZheng XiaoJi Extract, DME-25, on Endothelial Cells and their Response to Avastin.
    Owen S; Gao Y; Zhi X; Wei C; Wu Y; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1181-92. PubMed ID: 26977014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating endothelial cells in chronic lymphocytic leukemia: more evidence of disturbed angiogenesis.
    Kay NE
    Leuk Lymphoma; 2009 Jan; 50(1):8-9. PubMed ID: 19172495
    [No Abstract]   [Full Text] [Related]  

  • 45. Involvement of endothelial progenitor cells in tumor vascularization.
    Patenaude A; Parker J; Karsan A
    Microvasc Res; 2010 May; 79(3):217-23. PubMed ID: 20085777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccination approach to anti-angiogenic treatment of cancer.
    Wentink MQ; Huijbers EJ; de Gruijl TD; Verheul HM; Olsson AK; Griffioen AW
    Biochim Biophys Acta; 2015 Apr; 1855(2):155-71. PubMed ID: 25641676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current insights into the association of Nestin with tumor angiogenesis.
    Onisim A; Achimas-Cadariu A; Vlad C; Kubelac P; Achimas-Cadariu P
    J BUON; 2015; 20(3):699-706. PubMed ID: 26214620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of endothelial progenitor cells in breast cancer angiogenesis: from fundamental research to clinical ramifications.
    Le Bourhis X; Romon R; Hondermarck H
    Breast Cancer Res Treat; 2010 Feb; 120(1):17-24. PubMed ID: 20033768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumour-associated angiogenesis in human colorectal cancer.
    Rmali KA; Puntis MC; Jiang WG
    Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minimal model for tumor angiogenesis.
    Kevrekidis PG; Whitaker N; Good DJ; Herring GJ
    Phys Rev E Stat Nonlin Soft Matter Phys; 2006 Jun; 73(6 Pt 1):061926. PubMed ID: 16906883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular endothelial growth factor: basic science and clinical progress.
    Ferrara N
    Endocr Rev; 2004 Aug; 25(4):581-611. PubMed ID: 15294883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
    Wilson PM; LaBonte MJ; Lenz HJ
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.
    Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M
    Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell culture detection of microvascular cell death in clinical specimens of human neoplasms and peripheral blood.
    Weisenthal LM; Patel N; Rueff-Weisenthal C
    J Intern Med; 2008 Sep; 264(3):275-87. PubMed ID: 18793333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microvascular Mural Cells in Cancer.
    Östman A; Corvigno S
    Trends Cancer; 2018 Dec; 4(12):838-848. PubMed ID: 30470305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelets as messengers of early-stage cancer.
    Sabrkhany S; Kuijpers MJE; Oude Egbrink MGA; Griffioen AW
    Cancer Metastasis Rev; 2021 Jun; 40(2):563-573. PubMed ID: 33634328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The coagulome and the oncomir: impact of cancer-associated haemostatic dysregulation on the risk of metastasis.
    Burbury K; MacManus MP
    Clin Exp Metastasis; 2018 Apr; 35(4):237-246. PubMed ID: 29492795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selection of clinically useful angiogenesis-related biomarkers: an update.
    Todorović-Raković N; Vujasinović T; Abu Rabi Z
    Int J Biol Markers; 2012 Jul; 27(2):e65-81. PubMed ID: 22307386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.